Sector: Pharmaceuticals & Biotechnology

Small Cap

Medicamen Organics Share Price

Q: What is the Market Capitalization of Medicamen Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Medicamen Organics Ltd. is approximately ₹ 29.4 Cr.

Q: What are the PE and PB ratios for Medicamen Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Medicamen Organics Ltd. is 7.3, and the Price-to-Book (PB) ratio is 0.9.

Q: What is the 52-Week High and Low for Medicamen Organics Ltd.?

Over the past 52 weeks, the highest price reached by Medicamen Organics Ltd. shares was ₹ 49.7, and the lowest price was ₹ 20.05.

Q: Who are the major shareholders of Medicamen Organics Ltd.?

Significant shareholdings in Medicamen Organics Ltd. typically include entities such as: Promoter Public Other Institutions FII (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Medicamen Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Medicamen Organics Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Medicamen Organics Ltd.

₹24

-0.45(-1.84%)

Trade Now

25th May 2026 | 2:50 PM

NSE : MEDIORG

Open Free Demat Account

Medicamen Organics Performance

Price Movement

₹24.00

₹24.90

↘ Today's Low↗ Today's High

1 Year Performance

₹24.00

₹20.05

₹49.70

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹24.90

Low₹24.00

Open at₹24.45

Prev Close₹24.45

Volumes14.00 K

Avg Price₹24.45

Lower Circuit₹22.05

Upper Circuit₹26.85

Historical Performance

3M High₹32.00

3M Low₹20.05

1 Yr High₹49.70

1 Yr Low₹20.05

3 Yr High₹159.40

3 Yr Low₹19.60

5 Yr High₹159.40

5 Yr Low₹19.60

Medicamen Organics Fundamentals

Market Cap

Low in industry

29.40 Cr.

PE Ratio (TTM)

Low in industry

7.30

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

20% decr over last year

13.77

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Low in industry

0.90

MFI

MFI oversold

23.93

RSI

RSI is mid-range

EPS (TTM)

3.67

Debt to Equity

0.42

Face Value

Operating Profit Margin Qtr.

17.20

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.90

Medicamen Organics Financials

Data not available for chart

Indicator
No Record Found

Medicamen Organics Technicals

Medicamen Organics Ltd. EMA & SMA

₹24.00

-0.45 (-1.84%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹26.1

Day EMA10 ₹26.7

Day EMA12 ₹26.9

Day EMA20 ₹27.1

Day EMA26 ₹27

Day EMA50 ₹26.4

Day EMA100 ₹27

Day EMA200 ₹31.4

Medicamen Organics Support and Resistance

Resistance

First Resistance₹25.60

Second Resistance₹26.75

Third Resistance₹27.40

Support

First Support₹23.80

Second Support₹23.15

Third Support₹22.00

Technical Indicators

Day RSI38.00

Day MFI23.93

Day ADX19.99

Day Commodity Channel Index-141.90

William-97.90

Day MACD-0.07

Day MACD Signal Line0.46

Day ATR1.21

Day ROC125-33.20

Day ROC21-10.28

Medicamen Organics Shareholding Pattern

Held By	Sep 2024	Mar 2025	Sep 2025	Mar 2026
Promoter	59.7	59.7	59.7	59.7
FII	0.1	0.1	0	0.1
DII	3.8	3.8	3.8	1.6
Public	36.4	36.4	36.5	38.6

Medicamen Organics Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	74 K	86 K	86.05%
Week	21.5 K	24.5 K	87.76%
1 Month	10 K	12.53 K	79.79%
6 Month	12.53 K	14.76 K	84.88%

Medicamen Organics SWOT Analysis

Strengths5

Weakness9

Opportunity0

Threats0

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Companies with Low Debt

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Medicamen Organics Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Medicamen Organics Stock Comparison

Financials	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.	Medistep Healthcare Ltd.
Price (₹)	₹492.90	₹6.40	₹122	₹131.01	₹13.79	₹19.65
% Change	1.27%	-2.14%	-1.61%	0.71%	-0.86%	7.67%
Revenue TTM (₹ Cr)	-	₹83.60	-	₹287.68	-	-
Net Profit TTM (₹ Cr)	-	₹-34.95	-	₹14.88	-	-
PE TTM	-	-1.50	16.20	34.50	-	6.70
1 Year Return	24.95	544	-4.69	4.98	51.43	-54.3
ROCE	3.56	-5.63	-	-	-	-

Similar Stocks

INFLUX

Influx Healthtech Ltd.

₹ 236.10

-5.48%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 559.75

+0.46%

INNOVACAP

Innova Captab Ltd.

₹ 852.80

+0.53%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 78.00

+1.46%

SIGACHI

Sigachi Industries Ltd.

₹ 20.34

-0.05%

WINDLAS

Windlas Biotech Ltd.

₹ 784.40

-0.70%

VINEETLAB

Vineet Laboratories Ltd.

₹ 35.00

-1.69%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 556.00

+1.44%

ZIMLAB

Zim Laboratories Ltd.

₹ 99.45

-0.71%

MEDICO

Medico Remedies Ltd.

₹ 48.93

+2.28%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 198.45

+1.58%

LASA

Lasa Supergenerics Ltd.

₹ 8.07

+1.00%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 376.50

+0.36%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 302.20

-1.10%

ORTINGLOBE

Ortin Global Ltd.

₹ 15.06

BROOKS

Brooks Laboratories Ltd.

₹ 56.41

+4.99%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2243.00

-2.22%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 135.50

+0.35%

ALPA

Alpa Laboratories Ltd.

₹ 67.85

-1.89%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 371.45

-2.62%

NECLIFE

Nectar Lifesciences Ltd.

₹ 12.03

-0.25%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 29.01

-1.36%

INDOCO

Indoco Remedies Ltd.

₹ 195.70

-1.70%

FAQ's on MEDIORG

What is the Market Capitalization of Medicamen Organics Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Medicamen Organics Ltd. is approximately ₹ 29.4 Cr.

What are the PE and PB ratios for Medicamen Organics Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Medicamen Organics Ltd. is 7.3, and the Price-to-Book (PB) ratio is 0.9.

What is the 52-Week High and Low for Medicamen Organics Ltd.?

Over the past 52 weeks, the highest price reached by Medicamen Organics Ltd. shares was ₹ 49.7, and the lowest price was ₹ 20.05.

Who are the major shareholders of Medicamen Organics Ltd.?

Significant shareholdings in Medicamen Organics Ltd. typically include entities such as:

Promoter
Public
Other Institutions
FII

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Medicamen Organics Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Medicamen Organics Ltd. is often compared with other major players such as Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda, Rekvina Laboratories and Vivimed Labs for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy